Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology...
Provides expanded access to FDA and prioritized review of submission Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse...
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary CellFX® Nanosecond...
Oversubscribed offering expected to generate $60 million in immediate gross proceeds for the Company Warrants issued in the offering could...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.